DelveInsight’s, “Acute Lymphocytic Leukemia Pipeline Insight 2023” report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphoc… Read More
Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More
Clinscience and Ryvu Therapeutics sign Knowledge Administration and Biostatistics Settlement for RVU120 Section II Medical Trials in Hematology
Clinscience is thrilled to companion wit… Read More
[Research Report] The T cell therapy market size was valued at US$ 2,754.0 million in 2022 and is expected to reach US$ 9,035.01 million by 2030. It is estimated to register a CAGR of 1… Read More
HOUSTON — Intensive consolidation treatment before allogeneic stem-cell transplant did not improve outcomes in older patients with acute myeloid leukemia (AML), a retrospective com… Read More
History of Thalidomide
During the 1950s-1960s, thalidomide was widely used as an antiemetic for pregnant women, leading to a tragic outcome with thousands of cases of malformed babie… Read More
Facing backlash from doctors, patients, and advocacy groups, the Centers for Medicare & Medicaid Services (CMS) has backed down from a proposal that would have reduced reimbursement fo… Read More
Incyte Corporation, a leading biopharmaceutical company, has recently attracted attention from various research reports. These reports shed light on the company’s performance and provi… Read More
Incorporating quizartinib into standard treatment for newly diagnosed acute myeloid leukemia (AML) followed by maintenance therapy with the investigational FLT3 inhibitor improved survival… Read More
In today’s data-driven healthcare landscape, effective exchange and utilization of clinical data are critical for driving innovation, improving patient outcomes, and accelerating medic… Read More
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Iren… Read More
The U.S. Chamber of Commerce has filed a lawsuit to block implementation of Medicare drug-price negotiations included in the Inflation Reduction Act (IRA), following the lead of drug compa… Read More
If there’s one particular way to explain the markets a short while ago, that would be top-hefty. The mega-caps, the biggest US companies, have been outperforming the broader… Read More
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug di… Read More
Heavy-Duty Automotive Aftermarket Market
Looking forward, IMARC Group expects the market to reach a value of US$ 155.4 Billion by 2026
According to IMARC Group’s latest report, ti… Read More
Roots Analysis has done a detailed study on Novel Antibody Therapies Market covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
&nbs… Read More
CK1 functions
Protein phosphorylation mediated by protein kinases is essential for the activation and deactivation of many signaling pathways in cells. As a result, abnormal protein kinas… Read More
According to the information provided by The Fly, in a research note that was published on Thursday, securities analysts at Oppenheimer changed their recommendation for Fate Therapeutics (NA… Read More
For episode 10, we sit down with Kevin Caldwell, CEO & Co-Founder at Ossium Health. Stay tuned to find out what trend we’ll see continue as the field matures. First In Human… Read More
The partnership will Interrogate Patient Proteome Data to Drive Drug Discovery for high-risk subsets of Acute Myeloid Leukemia (AML)
Ordaōs, a biotechnology company designing no… Read More
Rigel Pharmaceuticals’ isocitrate dehydrogenase-1 mutant (mIDH1) targeting small molecule inhibitor Rezlidhia (olutasidenib) has won US Food and Drug Administration (FDA) approval for… Read More
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) is forging its own pathway in treating underserved diseases. And, for cancer patients, especially those resistant to or untreatable by current… Read More
The Minimal Residual Disease Market Research report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections… Read More
The occasion also saw Narayana Healthcare celebrating the completion of 2000 Bone Marrow Transplants
Plans to open 4 more Bone Marrow Transplant facilities across Ahmedabad, Raipur, Mys… Read More
Delveinsight Business Research LLP
As per DelveInsight, the Relapsed or Refractory Myelodysplastic Syndrome Therapeutics Market dynamics are expected to transform in the coming years ow… Read More
Ipsen has reportedly signed an exclusive global collaboration agreement with Accent Therapeutics Inc. to research, develop, produce, and promote the pre-clinical stage METTL3 program of Acce… Read More
Global Leading Companies & Different Growth Strategies Adopted by Them:The global pharmaceutical drug delivery market is highly competitive, with many leading market players based in dev… Read More